Printer Friendly

LIFECORE SIGNS RESEARCH AGREEMENT WITH IOLAB CORPORATION

 CHASKA, Minn., Nov. 25 ~PRNewswire~ -- Lifecore Biomedical, Inc. (NASDAQ: LCBM) announced today that it has signed a research agreement with the IOLAB Corporation, a Johnson & Johnson company, to develop a high molecular weight sodium hyaluronate based on Lifecore's microbial fermentation process for use in IOLAB's AMVISC(R) Brand ophthalmic viscoelastic surgical products.
 The agreement provides for IOLAB funding of the project in exchange for the right to negotiate an exclusive commercial supply agreement covering IOLAB's ophthalmic use of the high molecular weight hyaluronate. IOLAB would indemnify Lifecore for claims of patent infringement under USP 4141 973 assigned to Pharmacia AB which covers certain hyaluronic acid fractions.
 James W. Bracke, president and CEO of Lifecore, stated that, "Although there can be no assurance that Lifecore will be successful in developing a high molecular weight ophthalmic sodium hyaluronate suitable for IOLAB, or that Lifecore will subsequently enter into a commercial supply agreement, we believe Lifecore's experience has prepared the company for this challenge."
 Lifecore develops, manufactures and markets sterile medical devices for a variety of surgical applications, through both direct sales and OEM supplier relationships.
 -0- 11~25~92
 ~CONTACT: James W. Bracke or John C. Heinmiller, both of Lifecore Biomedical, 612-368-4300~
 (LCBM)


CO: Lifecore Biomedical, Inc.; IOLAB Corporation ST: Minnesota IN: MTC SU:

KH -- MN005 -- 1509 11~25~92 12:32 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 25, 1992
Words:221
Previous Article:FIRSTAT OF AMERICA ANNOUNCES MINNEAPOLIS OPENING
Next Article:COPLEY PHARMACEUTICAL, INC. RESPONDS TO REPORTED LITIGATION
Topics:


Related Articles
LIFECORE BIOMEDICAL REPORTS THIRD QUARTER RESULTS
LIFECORE BIOMEDICAL ANNOUNCES EXTENSION OF ALCON SUPPLY AGREEMENT
LIFECORE BIOMEDICAL REPORTS FISCAL 1992 RESULTS
LIFECORE BIOMEDICAL REPORTS FIRST QUARTER RESULTS; INCREASED ALCON ORDER
LIFECORE AND FIDIA ADVANCED BIOPOLYMERS S.R.L. SIGN HYALURONATE TECHNOLOGY AGREEMENT
LIFECORE SIGNS LETTER OF INTENT REVISING ETHICON PRODUCT DEVELOPMENT RELATIONSHIP
LIFECORE SIGNS HYALURONATE SUPPLY AGREEMENT WITH CHEMEDICA S.A.
LIFECORE RECEIVES ACCELERATED CHIRON VISION ORDER
LIFECORE TO SUPPLY MENTOR WITH OPHTHALMIC VISCOELASTIC SOLUTION
LIFECORE AND CHIRON VISION STRENGTHEN SUPPLY RELATIONSHIP

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters